11-101-5692
Ciprofloxacin Pharmaceutical Secondary Standard, MilliporeSigma™ Supelco™
Manufacturer: MilliporeSigma Supelco
CAS Number: 85721-33-1
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | 11-101-5692-Each-of-1 | In Stock | ₹ 11,926.00 |
11-101-5692 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 11,926.00
GST (18%): ₹ 2,146.68
Total Price: ₹ 14,072.68
CAS
85721-33-1
Type
Certified Reference Material
Linear Formula
C17H18 FN3O3
Synonym
1-Cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid; Ciprobay
Grade
Certified Reference Material
Quantity
1 g
Purity Grade Notes
These secondary standards offer multi-traceability to the USP, EP (PhEur) and BP primary standards, where they are available.
MDL Number
MFCD00185755
Formula Weight
331.34
Physical Form
Neat
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
Sigma Aldrich Fine Chemicals Biosciences Ciprofloxacin European Pharmacopoeia (EP) Reference Standard | 85721-33-1 | MFCD00185755 | | -- | ₹ 24,531.07 | ||
Sigma Aldrich Fine Chemicals Biosciences Ciprofloxacin United States Pharmacopeia (USP) Reference Standard | 85721-33-1 | MFCD00185755 | 200MG | -- | ₹ 39,903.15 | ||
Ciprofloxacin | -- | ₹ 11,077.80 | ||
Ciprofloxacin | -- | ₹ 11,988.00 | ||
Ciprofloxacin | -- | ₹ 34,176.90 | ||
Ciprofloxacin | -- | ₹ 3,563.10 - ₹ 13,974.90 | ||
Ciprofloxacin | -- | ₹ 3,563.10 - ₹ 13,974.90 | ||
1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid | -- | ₹ 445.00 - ₹ 6,052.00 | ||
Ciprofloxacin | -- | ₹ 4,450.00 - ₹ 9,612.00 | ||
85721-33-1 | 1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid | -- | ₹ 890.00 - ₹ 24,653.00 |
Related Products
Description
- Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.Ciprofloxacin is grouped under the class of second generation of quinolone analogs of nalidixic acid that exhibits high potency, minimal toxicity and a broad-spectrum antibacterial activity
- It can be administered both parenterally and orally
- It finds applications in the treatment of broad range of infections of the urinary tract, respiratory tract and gastrointestinal tract, as well as skin and soft tissue infections
- Featured Industries: Pharmaceutical (small molecule)